OAC
DFTX

OMERS Administration Corp’s Definium Therapeutics DFTX Stock Holding History

OMERS Administration Corp’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,600
Closed -$196K – 1231
2025
Q3 		$196K Buy
+16,600
New +$155K ﹤0.01% 985

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

OMERS Administration Corp's DFTX Position: Q4 2025 in Review

OMERS Administration Corp sold out of Definium Therapeutics (DFTX) in Q4 2025, closing a stake of 16,600 shares — an estimated $196K sold.

OMERS Administration Corp first reported a position in DFTX in Q3 2025 and held it in 1 quarter. The position peaked at $196K in Q3 2025. 208 funds tracked by Wall St. Rank hold DFTX as of Q4 2025.

  • OMERS Administration Corp reported no remaining Definium Therapeutics position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 16,600 Definium Therapeutics shares in Q4 2025, an estimated $196K.
  • OMERS Administration Corp first reported a position in Definium Therapeutics in Q3 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Definium Therapeutics position peaked at $196K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.